TY - JOUR
T1 - Hydrogen-peroxide generating electrochemical bandage is active in vitro against mono- and dual-species biofilms
AU - Raval, Yash S.
AU - Mohamed, Abdelrhman
AU - Flurin, Laure
AU - Mandrekar, Jayawant N.
AU - Greenwood Quaintance, Kerryl E.
AU - Beyenal, Haluk
AU - Patel, Robin
N1 - Funding Information:
This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under the grant number R01 AI091594. The authors would like to thank Henry Chambers III (University of California, San Francisco) for providing S. aureus USA100, USA200, and USA300; Caliper Life Sciences for providing S. aureus Xen 30, S. epidermidis Xen 43, and P. aeruginosa Xen 5; Daniel Hassett (University of Cincinnati) for providing P. aeruginosa PAO1, PA14, and PA14 Δkat AB; and the Antibacterial Resistance Leadership Group (supported by a grant from the National Institutes of Health through Duke University) for providing A. baumannii ARLG-1268. R.P. reports grants from CD Diagnostics, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, ContraFect, TenNor Therapeutics Limited, and Shionogi. R.P. is a consultant for Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, and Qvella; monies are paid to Mayo Clinic. In addition, R.P. has patents on Bordetella pertussis/parapertussis PCR, a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and an antibiofilm substance. R.P. receives travel reimbursement from ASM and IDSA, an editor's stipend from IDSA, and honoraria from the NBME, Up-to-Date, and the Infectious Diseases Board Review Course. H.B. holds a patent (US20180207301A1), “Electrochemical reduction or prevention of infections,” which refers to the electrochemical scaffold described herein.
Funding Information:
This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under the grant number R01 AI091594 . The authors would like to thank Henry Chambers III (University of California, San Francisco) for providing S. aureus USA100 , USA200 , and USA300 ; Caliper Life Sciences for providing S. aureus Xen 30, S. epidermidis Xen 43, and P. aeruginosa Xen 5; Daniel Hassett (University of Cincinnati) for providing P. aeruginosa PAO1, PA14, and PA14 Δkat AB; and the Antibacterial Resistance Leadership Group (supported by a grant from the National Institutes of Health through Duke University) for providing A. baumannii ARLG-1268.
Publisher Copyright:
© 2021 The Authors
PY - 2021/12
Y1 - 2021/12
N2 - Biofilms formed by antibiotic-resistant bacteria in wound beds present unique challenges in terms of treating chronic wound infections; biofilms formed by one or more than one bacterial species are often involved. In this work, the in vitro anti-biofilm activity of a novel electrochemical bandage (e-bandage) composed of carbon fabric and controlled by a wearable potentiostat, designed to continuously deliver low amounts of hydrogen peroxide (H2O2) was evaluated against 34 mono-species and 12 dual-species membrane bacterial biofilms formed by Staphylococcus aureus, S. epidermidis, Enterococcus faecium, E. faecalis, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Cutibacterium acnes, and Bacteroides fragilis. Biofilms were grown on polycarbonate membranes placed atop agar plates. An e-bandage, which electrochemically reduces dissolved oxygen to H2O2 when polarized at −0.6 VAg/AgCl, was then placed atop each membrane biofilm and polarized continuously for 12, 24, and 48 h using a wearable potentiostat. Time-dependent decreases in viable CFU counts of all mono- and dual-species biofilms were observed after e-bandage treatment. 48 h of e-bandage treatment resulted in an average reduction of 8.17 ± 0.40 and 7.99 ± 0.32 log10 CFU/cm2 for mono- and dual-species biofilms, respectively. Results suggest that the described H2O2 producing e-bandage can reduce in vitro viable cell counts of biofilms grown either in mono- or dual-species forms, and should be further developed as a potential antibiotic-free treatment strategy for treating chronic wound infections.
AB - Biofilms formed by antibiotic-resistant bacteria in wound beds present unique challenges in terms of treating chronic wound infections; biofilms formed by one or more than one bacterial species are often involved. In this work, the in vitro anti-biofilm activity of a novel electrochemical bandage (e-bandage) composed of carbon fabric and controlled by a wearable potentiostat, designed to continuously deliver low amounts of hydrogen peroxide (H2O2) was evaluated against 34 mono-species and 12 dual-species membrane bacterial biofilms formed by Staphylococcus aureus, S. epidermidis, Enterococcus faecium, E. faecalis, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Cutibacterium acnes, and Bacteroides fragilis. Biofilms were grown on polycarbonate membranes placed atop agar plates. An e-bandage, which electrochemically reduces dissolved oxygen to H2O2 when polarized at −0.6 VAg/AgCl, was then placed atop each membrane biofilm and polarized continuously for 12, 24, and 48 h using a wearable potentiostat. Time-dependent decreases in viable CFU counts of all mono- and dual-species biofilms were observed after e-bandage treatment. 48 h of e-bandage treatment resulted in an average reduction of 8.17 ± 0.40 and 7.99 ± 0.32 log10 CFU/cm2 for mono- and dual-species biofilms, respectively. Results suggest that the described H2O2 producing e-bandage can reduce in vitro viable cell counts of biofilms grown either in mono- or dual-species forms, and should be further developed as a potential antibiotic-free treatment strategy for treating chronic wound infections.
KW - Anti-biofilm
KW - Electrochemical bandage
KW - Hydrogen peroxide
KW - Membrane biofilm
KW - Wound infections
UR - http://www.scopus.com/inward/record.url?scp=85122649504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122649504&partnerID=8YFLogxK
U2 - 10.1016/j.bioflm.2021.100055
DO - 10.1016/j.bioflm.2021.100055
M3 - Article
AN - SCOPUS:85122649504
SN - 2590-2075
VL - 3
JO - Biofilm
JF - Biofilm
M1 - 100055
ER -